Search tips
Search criteria 


Logo of bmjcredLink to Publisher's site
Br Med J (Clin Res Ed). 1987 January 17; 294(6565): 152–154.
PMCID: PMC1245163

Relation between phenotype and banal melanocytic naevi.


In a study of risk factors for the development of melanocytic naevi in relation to the pathogenesis of malignant melanoma 197 white adults were examined by four dermatologists and naevus counts correlated with several other features. Highly significant associations were found between large numbers of banal acquired melanocytic naevi and the ability to tan easily without burning (skin types 3 and 4; relative risk 4.6), brown or hazel eyes (relative risk 3.5), green or grey eyes (relative risk 3.5) and brown or black hair (relative risk 3.7). No significant associations with numbers of naevi were shown for parity or use of oral contraceptives or other steroid hormones. This is the first study to find any relation between melanocytic naevi and phenotypic factors in a white population.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (712K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Elder DE, Goldman LI, Goldman SC, Greene MH, Clark WH., Jr Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer. 1980 Oct 15;46(8):1787–1794. [PubMed]
  • Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst. 1984 Feb;72(2):257–266. [PubMed]
  • Green A, MacLennan R, Siskind V. Common acquired naevi and the risk of malignant melanoma. Int J Cancer. 1985 Mar 15;35(3):297–300. [PubMed]
  • Swerdlow AJ, English J, MacKie RM, O'Doherty CJ, Hunter JA, Clark J, Hole DJ. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed) 1986 Jun 14;292(6535):1555–1559. [PMC free article] [PubMed]
  • Walton RG, Jacobs AH, Cox AJ. Pigmented lesions in newborn infants. Br J Dermatol. 1976 Oct;95(4):389–396. [PubMed]
  • Castilla EE, da Graça Dutra M, Orioli-Parreiras IM. Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies. Br J Dermatol. 1981 Mar;104(3):307–315. [PubMed]
  • PACK GT, LENSON N, GERBER DM. Regional distribution of moles and melanomas. AMA Arch Surg. 1952 Dec;65(6):862–870. [PubMed]
  • Nicholls EM. Genetic susceptibility and somatic mutation in the production of freckles, birthmarks and moles. Lancet. 1968 Jan 13;1(7533):71–73. [PubMed]
  • Nicholls EM. Development and elimination of pigmented moles, and the anatomical distribution of primary malignant melanoma. Cancer. 1973 Jul;32(1):191–195. [PubMed]
  • MacKie RM, English J, Aitchison TC, Fitzsimons CP, Wilson P. The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Br J Dermatol. 1985 Aug;113(2):167–174. [PubMed]
  • Cooke KR, Spears GF, Skegg DC. Frequency of moles in a defined population. J Epidemiol Community Health. 1985 Mar;39(1):48–52. [PMC free article] [PubMed]
  • Foucar E, Bentley TJ, Laube DW, Rosai J. A histopathologic evaluation of nevocellular nevi in pregnancy. Arch Dermatol. 1985 Mar;121(3):350–354. [PubMed]
  • Ellis DL, Wheeland RG. Increased nevus estrogen and progesterone ligand binding related to oral contraceptives or pregnancy. J Am Acad Dermatol. 1986 Jan;14(1):25–31. [PubMed]
  • GOLDMAN L, RICHFIELD DF. Effect of corticotropin and cortisone on development and progress of pigmented nevi. J Am Med Assoc. 1951 Nov 3;147(10):941–943. [PubMed]
  • Coleman WP, 3rd, Gately LE, 3rd, Krementz AB, Reed RJ, Krementz ET. Nevi, lentigines, and melanomas in blacks. Arch Dermatol. 1980 May;116(5):548–551. [PubMed]
  • Kopf AW, Lazar M, Bart RS, Dubin N, Bromberg J. Prevalence of nevocytic nevi on lateral and medial aspects of arms. J Dermatol Surg Oncol. 1978 Feb;4(2):153–158. [PubMed]
  • Melski JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol. 1977 Jun;68(6):328–335. [PubMed]
  • Lee JA. Melanoma and exposure to sunlight. Epidemiol Rev. 1982;4:110–136. [PubMed]

Articles from British Medical Journal (Clinical Research Ed.) are provided here courtesy of BMJ Publishing Group